Valuation: Ipca Laboratories Limited

Market Cap 500B 5.22B 4.58B 4.32B 3.94B 7.38B 7.43B 51.74B 20.04B 255B 19.59B 19.16B 821B P/E 2027 *
32.9x
P/E 2028 * 28.2x
Enterprise Value 489B 5.11B 4.48B 4.23B 3.86B 7.22B 7.27B 50.64B 19.61B 250B 19.17B 18.76B 803B EV / Sales 2027 *
4.45x
EV / Sales 2028 * 3.91x
Free-Float
54.94%
Yield 2027 *
0.29%
Yield 2028 * 0.31%
1 day-1.36%
1 week-2.06%
Current month-0.28%
1 month+2.04%
3 months+21.75%
6 months+25.17%
Current year+38.30%
1 week 1,948.1
Extreme 1948.1
2,039.3
1 month 1,906.85
Extreme 1906.85
2,039.3
Current year 1,392
Extreme 1392
2,039.3
1 year 1,252.95
Extreme 1252.95
2,039.3
3 years 897.95
Extreme 897.95
2,039.3
5 years 670
Extreme 670
2,039.3
10 years 200
Extreme 200
2,039.3
Manager TitleAgeSince
Chief Executive Officer 53 2023-03-31
Chief Executive Officer 70 2023-03-31
Chief Tech/Sci/R&D Officer 52 2023-10-15
Director TitleAgeSince
Chairman 79 2012-07-04
Director/Board Member 53 2008-11-10
Director/Board Member 70 1994-07-31
Change 5-day change 1-year change 3-year change Capi.($)
-1.36%-2.06% - - 5.22B
+0.13%+2.65%+65.61%+114.28% 1,055B
+0.20%+0.46%+52.60%+69.24% 654B
-0.29%+0.14%+20.96%+70.93% 467B
-0.85%+0.98%+41.29%+44.38% 348B
+0.71%+4.08%+22.24%+29.51% 275B
+1.23%+0.42%+14.57%+12.13% 258B
+2.11%+7.51%+52.89%+55.37% 224B
+0.83%+0.55%+35.99%+101.70% 187B
0.00%-10.14%-29.94%-60.30% 171B
Average +0.19%+0.74%+30.69%+48.58% 404.26B
Weighted average by Cap. +0.02%+1.32%+41.54%+67.83%

Financials

2027 *2028 *
Net sales 110B 1.15B 1.01B 951M 866M 1.62B 1.63B 11.38B 4.41B 56.17B 4.31B 4.21B 181B 123B 1.28B 1.12B 1.06B 967M 1.81B 1.82B 12.69B 4.92B 62.66B 4.81B 4.7B 201B
Net income 15.15B 158M 139M 131M 119M 223M 225M 1.57B 607M 7.74B 593M 580M 24.87B 17.8B 186M 163M 154M 140M 263M 264M 1.84B 713M 9.09B 697M 682M 29.22B
Net Debt -10.65B -111M -97.51M -92.09M -83.92M -157M -158M -1.1B -427M -5.44B -417M -408M -17.49B -19.96B -208M -183M -173M -157M -294M -296M -2.06B -800M -10.2B -782M -765M -32.77B
Logo Ipca Laboratories Limited
Ipca Laboratories Limited is an India-based integrated pharmaceutical company. The Company is engaged in manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. It offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The Company offers brands, such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The Company’s products are sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing APIs and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc. and Ipca Pharma Nigeria Ltd.
Employees
17,210
Date Price Change Volume
26-09-25 ₹1,969.50 -1.36% 15,780
26-09-24 ₹1,996.65 +1.70% 18,930
26-09-23 ₹1,963.25 -1.45% 5,082
26-09-22 ₹1,992.20 -0.79% 5,828
26-09-21 ₹2,008.05 -0.15% 10,576
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
1,970.80INR
Average target price
1,972.28INR
Spread / Average Target
+0.07%

Quarterly revenue - Rate of surprise